Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 2/20 | 0.49 |
| ▸ | CNR1 | P21554 | 3/20 | 0.48 |
| ▸ | PLCD1 | P51178 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.41 |
| ▸ | HLCS | P50747 | 2/20 | 0.40 |
| ▸ | F2 | P00734 | 1/20 | 0.37 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.37 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.37 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.37 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | ABL1 | P00519 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | IDE | P14735 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30400770 | 0.85 | CNR2 (0.57) | CNR2CNR1 | |
| SCHEMBL23521224 | 0.85 | CNR2 (0.57) | CNR2CNR1 | |
| SCHEMBL29910361 | 0.85 | CNR2 (0.57) | CNR2CNR1 | |
| SCHEMBL29429640 | 0.80 | CNR2 (0.73) | CNR2CNR1TDP1HLCSMEN1 | |
| SCHEMBL9951988 | 0.80 | S1PR1 (0.49) | — | |
| SCHEMBL17595343 | 0.80 | S1PR1 (0.49) | — | |
| SCHEMBL2340054 | 0.80 | S1PR1 (0.49) | — | |
| SCHEMBL23142625 | 0.79 | CNR2 (0.56) | CNR2CNR1 | |
| SCHEMBL23142658 | 0.79 | CNR2 (0.58) | CNR2CNR1 | |
| SCHEMBL30824302 | 0.79 | CNR2 (0.58) | CNR2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011066221-A1 | IMMUNOGEN PRIORITIZATION FOR VACCINE DESIGN | INTERNATIONAL AIDS VACCINE INITIATIVE (US) | 2011-06-03 | — | — | WO | disclosed |